Emily M. Leproust - 06 Oct 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
President & CEO, Director
Signature
/s/ William Solis, as Attorney-in-Fact for Emily M. Leproust
Issuer symbol
TWST
Transactions as of
06 Oct 2021
Net transactions value
-$821,939
Form type
4
Filing time
08 Oct 2021, 16:35:14 UTC
Previous filing
06 Oct 2021
Next filing
15 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $41,412 +6,960 +4% $5.95 179,442 06 Oct 2021 Direct
transaction TWST Common Stock Sale $381,718 -3,940 -2.2% $96.88 175,502 06 Oct 2021 Direct F1, F2
transaction TWST Common Stock Sale $285,720 -2,920 -1.7% $97.85 172,582 06 Oct 2021 Direct F1, F3
transaction TWST Common Stock Sale $9,868 -100 -0.06% $98.68 172,482 06 Oct 2021 Direct F1
transaction TWST Common Stock Options Exercise $10,353 -1,740 -0.99% $5.95 174,222 07 Oct 2021 Direct
transaction TWST Common Stock Sale $76,042 -757 -0.43% $100.45 173,465 07 Oct 2021 Direct F1, F4
transaction TWST Common Stock Sale $99,651 -983 -0.57% $101.37 172,482 07 Oct 2021 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -6,960 -9.8% $0.000000 63,733 06 Oct 2021 Common Stock 6,960 $5.95 Direct F9
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -1,740 -2.7% $0.000000 61,993 07 Oct 2021 Common Stock 1,740 $5.95 Direct F9
holding TWST Employee Stock Option (right to buy) 266,539 06 Oct 2021 Common Stock 0 $26.66 Direct F6
holding TWST Employee Stock Option (right to buy) 131,290 06 Oct 2021 Common Stock 0 $23.33 Direct F7
holding TWST Employee Stock Option (right to buy) 186,672 06 Oct 2021 Common Stock 0 $8.82 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 28, 2021.
F2 Represents the weighted average sales price per share. The shares sold at prices ranging from $96.535 to $97.51 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3 Represents the weighted average sales price per share. The shares sold at prices ranging from $97.54 to $98.35 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F4 Represents the weighted average sales price per share. The shares sold at prices ranging from $100.05 to $101.02 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F5 Represents the weighted average sales price per share. The shares sold at prices ranging from $101.16 to $101.93 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F6 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F7 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F8 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F9 The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.